Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2000 Apr;108(4):289–291. doi: 10.1289/ehp.108-1638026

Phlebotomy increases cadmium uptake in hemochromatosis.

A Akesson 1, P Stål 1, M Vahter 1
PMCID: PMC1638026  PMID: 10753085

Abstract

The intestinal absorption of the nephrotoxic environmental pollutant cadmium increases markedly when iron stores are depleted. This may be mediated by an up regulation of the recently identified mucosal transporter DMT1 (Nramp2 or DCT1) for divalent cations. We tested whether the highly increased iron absorption in hereditary hemochromatosis (HH) was accompanied by an enhanced absorption of cadmium and lead. Cadmium and lead in blood and iron status markers were determined in 21 nonsmoking subjects with HH genetically tested for the HFE mutations and in 21 nonsmoking controls matched for age and sex. In subjects with HH on maintenance phlebotomy treatment, blood concentrations of cadmium, but not lead, were significantly higher than in paired controls. There was a strong age-independent positive association between blood cadmium and the number of years of phlebotomy treatment. Blood lead showed a similar but less pronounced consequence of treatment. All HH subjects with lower blood cadmium than the corresponding controls had either no mutation in the HFE gene, were not phlebotomized, or were phlebotomized for only a limited time. Our findings indicate that the treatment rather than the disease increased the cadmium uptake in homozygous HH. Further studies are needed to confirm whether the disease decreased cadmium absorption and whether the absorption was dependent on the genotype.

Full text

PDF
289

Images in this article

290Figure 1
on p.290
291Figure 2
on p.291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews N. C., Levy J. E. Iron is hot: an update on the pathophysiology of hemochromatosis. Blood. 1998 Sep 15;92(6):1845–1851. [PubMed] [Google Scholar]
  2. Bacon B. R., Powell L. W., Adams P. C., Kresina T. F., Hoofnagle J. H. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology. 1999 Jan;116(1):193–207. doi: 10.1016/s0016-5085(99)70244-1. [DOI] [PubMed] [Google Scholar]
  3. Baecklund M., Pedersen N. L., Björkman L., Vahter M. Variation in blood concentrations of cadmium and lead in the elderly. Environ Res. 1999 Apr;80(3):222–230. doi: 10.1006/enrs.1998.3895. [DOI] [PubMed] [Google Scholar]
  4. Barton J. C., Patton M. A., Edwards C. Q., Griffen L. M., Kushner J. P., Meeks R. G., Leggett R. W. Blood lead concentrations in hereditary hemochromatosis. J Lab Clin Med. 1994 Aug;124(2):193–198. [PubMed] [Google Scholar]
  5. Berglund M., Akesson A., Nermell B., Vahter M. Intestinal absorption of dietary cadmium in women depends on body iron stores and fiber intake. Environ Health Perspect. 1994 Dec;102(12):1058–1066. doi: 10.1289/ehp.941021058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cardoso E. M., Stål P., Hagen K., Cabeda J. M., Esin S., de Sousa M., Hultcrantz R. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med. 1998 Mar;243(3):203–208. doi: 10.1046/j.1365-2796.1998.00270.x. [DOI] [PubMed] [Google Scholar]
  7. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Jr, Ellis M. C., Fullan A. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar]
  8. Feder J. N., Penny D. M., Irrinki A., Lee V. K., Lebrón J. A., Watson N., Tsuchihashi Z., Sigal E., Bjorkman P. J., Schatzman R. C. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1472–1477. doi: 10.1073/pnas.95.4.1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Finch C. Regulators of iron balance in humans. Blood. 1994 Sep 15;84(6):1697–1702. [PubMed] [Google Scholar]
  10. Flanagan P. R., McLellan J. S., Haist J., Cherian G., Chamberlain M. J., Valberg L. S. Increased dietary cadmium absorption in mice and human subjects with iron deficiency. Gastroenterology. 1978 May;74(5 Pt 1):841–846. [PubMed] [Google Scholar]
  11. Fleming M. D., Romano M. A., Su M. A., Garrick L. M., Garrick M. D., Andrews N. C. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1148–1153. doi: 10.1073/pnas.95.3.1148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fleming M. D., Trenor C. C., 3rd, Su M. A., Foernzler D., Beier D. R., Dietrich W. F., Andrews N. C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997 Aug;16(4):383–386. doi: 10.1038/ng0897-383. [DOI] [PubMed] [Google Scholar]
  13. Fleming R. E., Migas M. C., Zhou X., Jiang J., Britton R. S., Brunt E. M., Tomatsu S., Waheed A., Bacon B. R., Sly W. S. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3143–3148. doi: 10.1073/pnas.96.6.3143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goyer R. A. Toxic and essential metal interactions. Annu Rev Nutr. 1997;17:37–50. doi: 10.1146/annurev.nutr.17.1.37. [DOI] [PubMed] [Google Scholar]
  15. Gross C. N., Irrinki A., Feder J. N., Enns C. A. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J Biol Chem. 1998 Aug 21;273(34):22068–22074. doi: 10.1074/jbc.273.34.22068. [DOI] [PubMed] [Google Scholar]
  16. Gunshin H., Mackenzie B., Berger U. V., Gunshin Y., Romero M. F., Boron W. F., Nussberger S., Gollan J. L., Hediger M. A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997 Jul 31;388(6641):482–488. doi: 10.1038/41343. [DOI] [PubMed] [Google Scholar]
  17. Han O., Fleet J. C., Wood R. J. Reciprocal regulation of HFE and NNamp2 gene expression by iron in human intestinal cells. J Nutr. 1999 Jan;129(1):98–104. doi: 10.1093/jn/129.1.98. [DOI] [PubMed] [Google Scholar]
  18. Järup L., Berglund M., Elinder C. G., Nordberg G., Vahter M. Health effects of cadmium exposure--a review of the literature and a risk estimate. Scand J Work Environ Health. 1998;24 (Suppl 1):1–51. [PubMed] [Google Scholar]
  19. Lebrón J. A., Bennett M. J., Vaughn D. E., Chirino A. J., Snow P. M., Mintier G. A., Feder J. N., Bjorkman P. J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 1998 Apr 3;93(1):111–123. doi: 10.1016/s0092-8674(00)81151-4. [DOI] [PubMed] [Google Scholar]
  20. Lee P. L., Gelbart T., West C., Halloran C., Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol Dis. 1998 Jun;24(2):199–215. doi: 10.1006/bcmd.1998.0186. [DOI] [PubMed] [Google Scholar]
  21. Parkkila S., Waheed A., Britton R. S., Bacon B. R., Zhou X. Y., Tomatsu S., Fleming R. E., Sly W. S. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13198–13202. doi: 10.1073/pnas.94.24.13198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Parkkila S., Waheed A., Britton R. S., Feder J. N., Tsuchihashi Z., Schatzman R. C., Bacon B. R., Sly W. S. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2534–2539. doi: 10.1073/pnas.94.6.2534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pietrangelo A. Hemochromatosis 1998: is one gene enough? J Hepatol. 1998 Sep;29(3):502–509. doi: 10.1016/s0168-8278(98)80074-3. [DOI] [PubMed] [Google Scholar]
  24. Raja K. B., Pountney D., Bomford A., Przemioslo R., Sherman D., Simpson R. J., Williams R., Peters T. J. A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis. Gut. 1996 May;38(5):765–769. doi: 10.1136/gut.38.5.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Roy C. N., Penny D. M., Feder J. N., Enns C. A. The hereditary hemochromatosis protein, HFE, specifically regulates transferrin-mediated iron uptake in HeLa cells. J Biol Chem. 1999 Mar 26;274(13):9022–9028. doi: 10.1074/jbc.274.13.9022. [DOI] [PubMed] [Google Scholar]
  26. Salter-Cid L., Brunmark A., Li Y., Leturcq D., Peterson P. A., Jackson M. R., Yang Y. Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5434–5439. doi: 10.1073/pnas.96.10.5434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Staessen J. A., Roels H. A., Emelianov D., Kuznetsova T., Thijs L., Vangronsveld J., Fagard R. Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group. Lancet. 1999 Apr 3;353(9159):1140–1144. doi: 10.1016/s0140-6736(98)09356-8. [DOI] [PubMed] [Google Scholar]
  28. Su M. A., Trenor C. C., Fleming J. C., Fleming M. D., Andrews N. C. The G185R mutation disrupts function of the iron transporter Nramp2. Blood. 1998 Sep 15;92(6):2157–2163. [PubMed] [Google Scholar]
  29. Vahter M., Berglund M., Lind B., Jorhem L., Slorach S., Friberg L. Personal monitoring of lead and cadmium exposure--a Swedish study with special reference to methodological aspects. Scand J Work Environ Health. 1991 Feb;17(1):65–74. doi: 10.5271/sjweh.1732. [DOI] [PubMed] [Google Scholar]
  30. Waheed A., Parkkila S., Saarnio J., Fleming R. E., Zhou X. Y., Tomatsu S., Britton R. S., Bacon B. R., Sly W. S. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1579–1584. doi: 10.1073/pnas.96.4.1579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Waheed A., Parkkila S., Zhou X. Y., Tomatsu S., Tsuchihashi Z., Feder J. N., Schatzman R. C., Britton R. S., Bacon B. R., Sly W. S. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12384–12389. doi: 10.1073/pnas.94.23.12384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Zoller H., Pietrangelo A., Vogel W., Weiss G. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet. 1999 Jun 19;353(9170):2120–2123. doi: 10.1016/S0140-6736(98)11179-0. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES